The recommended dose of the drug is 2mg/day with 0.5mg or 1mg as the starting dose for the treatment of major depressive disorder, while a dose of 2mg to 4mg/day can be used for the treatment of ...

Cognitive impairment, including decreased attention and memory, remains one of the most disabling aspects of schizophrenia, affecting the social life of patients. However, no effective treatment has ...

In a randomized clinical trial, researchers determined whether brexpiprazole is an efficacious, safe, and well-tolerated treatment for agitation in patients with Alzheimer dementia. Brexpiprazole, 2 ...

Learn everything you need to know about Brexpiprazole-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, ...

For many people living with dementia and their caregivers, the worst symptom of the disease is not memory loss, but agitation. Whether it comes out as verbal insults or physical violence, agitation in ...

Rexulti is an atypical antipsychotic medication prescribed to adults for depression, schizophrenia, and agitation linked to dementia in Alzheimer’s disease, and for schizophrenia in children ages 13 ...

WINDSOR, England and VALBY, Denmark, March 13, 2025 /PRNewswire/ -- Otsuka Pharmaceutical Europe Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced that the European Commission (EC) has ...

The approval of brexpiprazole is based on two late-stage studies, which showed significant improvement in calming agitated patients with Alzheimer's, when compared with a placebo. The decision comes ...

According to the letter, the application could not be approved due to lack of substantial efficacy from the submitted studies. The Food and Drug Administration (FDA) has issued a Complete Response ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with agitation in Alzheimer’s dementia were ...